In addition to identifying variants of CCL27 with distinct pharmacological properties, AF models of complexes of CCR10 and CCR3 with CCL27 and CCL28 also provided insight into the ability of CCR10 to be activated by both CCL27 and CCL28 and the specificity of CCR3 for CCL28. The gene discussed is CCR3; the disease is atrial fibrillation.